The Federal Institute for Medicinal Products and Medical Devices (BfArM) is circulating a warning against counterfeits of the 25 mg and 50 mg strengths of the cancer drug Sutent^® produced by Pfizer. The counterfeits that are parallel imported can be identified based on visible differences in hard capsules and foil sealing of the plastic bottle.

risk information - full text (available in German only)